ENGINEERING AN INTRACELLULAR PATHWAY FOR MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II PRESENTATION OF ANTIGENS

被引:302
作者
WU, TC
GUARNIERI, FG
STAVELEYOCARROLL, KF
VISCIDI, RP
LEVITSKY, HI
HEDRICK, L
CHO, KR
AUGUST, JT
PARDOLL, DM
机构
[1] JOHNS HOPKINS MED INST, DEPT PATHOL, BALTIMORE, MD 21287 USA
[2] JOHNS HOPKINS MED INST, DEPT PHARMACOL & MOLEC SCI, BALTIMORE, MD 21287 USA
[3] JOHNS HOPKINS MED INST, DEPT SURG, BALTIMORE, MD 21287 USA
[4] JOHNS HOPKINS MED INST, DEPT PEDIAT, BALTIMORE, MD 21287 USA
[5] JOHNS HOPKINS MED INST, DEPT ONCOL, BALTIMORE, MD 21287 USA
关键词
HUMAN PAPILLOMAVIRUS; LAMP-1; RECOMBINANT VACCINIA;
D O I
10.1073/pnas.92.25.11671
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The presentation of antigenic peptides by major histocompatibility complex (MHC) class II molecules to CD4(+) T cells is critical to the function of the immune system, In this study, we have utilized the sorting signal of the lysosomal-associated membrane protein LAMP-1 to target a model antigen, human papillomavirus 16 E7 (HPV-16 E7), into the endosomal and lysosomal compartments, The LAMP-I sorting signal reroutes the antigen into the MHC class ZI processing pathway, resulting in enhanced presentation to CD4(+) cells in vitro. In vivo immunization experiments in mice demonstrated that vaccinia containing the chimeric E7/LAMP-1 gene generated greater E7-specific lymphoproliferative activity, antibody titers, and cytotoxic T-lymphocyte activities than vaccinia containing the wild-type HPV-16 E7 gene, These results suggest that specific targeting of an antigen to the endosomal and lysosomal compartments enhances MHC class II presentation and vaccine potency.
引用
收藏
页码:11671 / 11675
页数:5
相关论文
共 41 条